The gift was made through Dr. Anne Keenleyside's estate, a Trent University professor of bioarchaeology who passed away in October of 2022 due to cancer. Lesley Heighway, PRHC Foundation president and CEO says the bequest has been invested in equipment and technology that support cancer care innovation, following Keenleyside’s request.
“Anne was clear she wanted her gift to connect her passion for scientific innovation with her desire to help the patients who would come after her. “Her generosity has allowed the PRHC Foundation to fund a second MRI for PRHC’s Diagnostic Imaging Department, as well as fully upgrading a general operating suite with state-of-the-art minimally invasive surgical tools – one of four undertaken by the Foundation,” she said. “By directing her bequest to the MRI and our minimally invasive surgical suites, her gift is already helping our hospital increase capacity and image quality for diagnostic scans and giving our general surgeons access to brand new, leading-edge tools to perform cancer surgeries.”